Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTSC short volume hasn't changed much with heavier volume

Exactly. The $180,000 figure relates to PDSG revenue. It would be misleading to use that figure as representing anything other than PDSG revenue. The purpose of asking the question was simply to highlight this, lest anyone mistakenly took it to mean PDS revenue.

Opty

Share
New Message
Please login to post a reply